Face to Face with Regeneration – Dexpanthenol Usefulness in the Eye Surface Disorders Based on Clinical Cases
Wydanie 4/2023
str. 59–63
Autor: Paulina Szabelska1,2, Joanna Gołębiewska1,2, Radosław Różycki1,3
1 Klinika Okulistyczna Wojskowego Instytutu Medycyny Lotniczej w Warszawie – Kierownik: dr n. med. Radosław Różycki
2 Centrum Medyczne Świat Oka w Warszawie
3 Centrum Medyczne Orbita w Warszawie
Summary:
Dry eye disease is a condition affecting the eye surface, therefore affecting the structures of both the ocular surface and the appendages, including: the tear film, lacrimal glands, Meibomian glands, as well as the cornea, conjunctiva and the eyelids. According to available literature symptoms of dry eye disease occur in 30% to 50% or even to 75% in patients who participate ophthalmological appointments. Similar symptoms can be reported by individuals in the case of other eye surface pathologies, such as erosion, chemical, thermal or infectious damage of cornea, keratopathies or in perioperative care during surgical procedures on the eye surface.
Dexpanthenol, the one of the ingredients of some moisturizing eyedrops, is used as additional treatment of eye surface diseases, due to its positive effect on the epithelium function and a moisturizing and regenerating effect. Our publication presents clinical cases of patients who received treatment with dexpanthenol as a part of the performed therapy.
Due to dry eye disease and other ocular surface disorders occurrence, which are the main reasons for patients to visit ophthalmologists, the proper diagnosis and treatment of these is an extremely important issue in the ophthalmological practice. Challenge for future clinical trials will be to create the therapeutic algorithms in which dexpanthenol can be used in the ophthalmological as a part of ophthalmological therapy.